IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bioblast Pharma LTD

CUSIP: M20156101 | 32 institutional holders

Quarters

Q2 2017Q1 2017Q4 2016Q3 2016Q2 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2017

Renaissance Technologies LLC207,700
0.0% of portfolio›$139
Wedbush Securities Inc37,500
0.0% of portfolio›$25
HighTower Advisors, LLC24,000
0.0% of portfolio›$17
Oppenheimer & Co Inc13,100
0.0% of portfolio›$8
Two Sigma Securities, LLC12,748
0.0% of portfolio›$9
KCG Holdings, Inc.11,468
0.0% of portfolio›$8
UBS Group AG6,200
0.0% of portfolio›$4
Ladenburg Thalmann Financial Services Inc1,000
0.0% of portfolio›$1
Morgan Stanley713
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Renaissance Technologies LLC
207,700$1390.0%CoreHighNew York, NY2017-08-11
Wedbush Securities Inc
37,500$250.0%CoreLowPasadena, CA2017-08-02
HighTower Advisors, LLC
24,000$170.0%IndexLowChicago, IL2017-09-22
Oppenheimer & Co Inc
13,100$80.0%CoreLowNew York, NY2017-08-09
Two Sigma Securities, LLC
12,748$90.0%ValueVery HighNew York, NY2017-08-14
KCG Holdings, Inc.
11,468$80.0%N/AN/AJersey City, NJ2017-08-11
UBS Group AG
6,200$40.0%CoreMediumZurich, Switzerland2017-11-14
Ladenburg Thalmann Financial Services Inc
1,000$10.0%N/AN/AMiami, FL2017-08-14
Morgan Stanley
713$00.0%CoreLowNew York, NY2017-08-11